Désolé, cet article est seulement disponible en anglais américain.
Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Projets Transversaux
Projets
CV
ACADEMIC BACKGROUND 2018 HDR in Biomathematics - Habilitation à diriger des recherches, Paris Saclay University, UVSQ 2005 – 2009 PhD in Biomathematics - Public Health: Epidemiology and science of biomedical information. University Pierre and Marie Curie, Paris VI, ED 393. 2000 – 2003 Engineer ENSIMAG (Graduate School of Engineering in Applied Mathematics and Computer Science, French equivalent for Master of Computer Science and Applied Mathematics) – Grenoble, France 2002 – 2003 Licenciatura in University of mathematics and statistics (5th year) member of UPC (Universitat Politécnica de Catalunya), Barcelona, Spain 1997 – 2000 Special intensive courses of advanced mathematics and physics (undergraduate level) LABS - 2012-. Assistant professor > Professor. Versailles Saint Quentin University, EMEA unit UMR1018, Institut Pasteur / INSERM /UVSQ, France. Mathematical Modelling and statistical inference of the dynamics of transmission of pathogens in population, with a focus on pathogen-pathogen, host-pathogen interactions, and antimicrobial resistance. - 2009-12 Research Associate (POST DOC). MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College, London. Mathematical modelling and statistical inference for a better understanding of the spread of pathogens in populations. - 2005–09 Institut Pasteur / U657 INSERM, Pharmaco-Epidemiology applied to Infectious Diseases laboratory (PhEMI) - 2003–04 CRG (Centre of Genomic Regulation), Microarrays Laboratory and GRIB (Group of Research in Bio-medicine and Computer Science), Chemogenomics Laboratory – Barcelona, Spain CONFERENCE ORGANISATION/CO-ORGANISATION 2019 SPHINx conference on disease transmission in healthcare settings 2018 Joint Pasteur-Oxford workshop on antibiotic resistance in South East Asia2018 2018 International conference on antimicrobial resistance, Institut Pasteur 2013-. SaMMBA monthly seminars - Statistical and Mathematical Modeling in Biological Applications, Institut Pasteur in Paris ( https://research.pasteur.fr/en/project/sammba-seminars/) 2012 WARM international workshop on modelling bacterial resistance in Paris Expertise activities Since 2016 Expertise for World Health Organization (WHO) - Asia on antibiotic resistance Since 2013 Elected member of the scientific board of the UFR Simone Veil Medical school Since 2017 Nominated member of Comité Scientifique de l'ITMO "Immunologie-Inflammation-infectiologie-Microbiologie" (I3M) Since 2017 Elected member COMESP Institut Pasteur evaluation committee
Publications
Télécharger-
2022Modelling the impact of antimicrobial use and external introductions on commensal E. coli colistin resistance in small-scale chicken farms of the Mekong delta of Vietnam., Transbound Emerg Dis 2022 Apr; (): .
-
2022Contributions of modelling for the control of COVID-19 nosocomial transmission., Anaesth Crit Care Pain Med 2022 Mar; 41(2): 101054.
-
2022Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study., BMJ Glob Health 2022 02; 7(2): .
-
2022Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk., Nat Commun 2022 01; 13(1): 236.
-
2021Lockdown impact on age-specific contact patterns and behaviours, France, April 2020., Euro Surveill 2021 12; 26(48): .
-
2021SARS-CoV-2 transmission across age groups in France and implications for control., Nat Commun 2021 11; 12(1): 6895.
-
2021How well does SARS-CoV-2 spread in hospitals?, accepted Emerging Infectious Diseases.
-
2021Hospital-level work organization drives the spread of SARS-CoV-2 within hospitals: insights from a multi-ward model, MedRxiv.
-
2021Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control., Elife 2021 09; 10(): .
-
2021The impact of co-circulating pathogens on SARS-CoV-2/COVID-19 Surveillance How concurrent epidemics may introduce bias and decrease the observed SARS-CoV-2 percent positivity., J Infect Dis 2021 Sep; (): .
-
+Voir la liste complète de publications